Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1471-2350-12-49
Title: | Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy | Authors: | Almind, G.J Grønskov, K Milea, D Larsen, M Brøndum-Nielsen, K Ek, J |
Keywords: | adult article autosomal dominant optic atrophy chromosome rearrangement clinical article Denmark DNA sequence family gene deletion gene mutation genetic screening genome human male multiplex ligation dependent probe amplification phenotype point mutation prevalence segregation analysis adolescent Caucasian child copy number variation female gene duplication gene locus genetics human genome middle aged pathology pathophysiology pedigree guanosine triphosphatase OPA1 protein, human Adolescent Adult Child Denmark DNA Copy Number Variations European Continental Ancestry Group Female Gene Duplication Genetic Loci Genome, Human GTP Phosphohydrolases Humans Male Middle Aged Optic Atrophy, Autosomal Dominant Pedigree Sequence Deletion Young Adult |
Issue Date: | 2011 | Citation: | Almind, G.J, Grønskov, K, Milea, D, Larsen, M, Brøndum-Nielsen, K, Ek, J (2011). Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy. BMC Medical Genetics 12 : 49. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2350-12-49 | Rights: | Attribution 4.0 International | Abstract: | Background: Autosomal dominant optic atrophy (ADOA, Kjer disease, MIM #165500) is the most common form of hereditary optic neuropathy. Mutations in OPA1 located at chromosome 3q28 are the predominant cause for ADOA explaining between 32 and 89% of cases. Although deletions of OPA1 were recently reported in ADOA, the frequency of OPA1 genomic rearrangements in Denmark, where ADOA has a high prevalence, is unknown. The aim of the study was to identify copy number variations in OPA1 in Danish ADOA patients.Methods: Forty unrelated ADOA patients, selected from a group of 100 ADOA patients as being negative for OPA1 point mutations, were tested for genomic rearrangements in OPA1 by multiplex ligation probe amplification (MLPA). When only one probe was abnormal results were confirmed by additional manually added probes. Segregation analysis was performed in families with detected mutations when possible.Results: Ten families had OPA1 deletions, including two with deletions of the entire coding region and eight with intragenic deletions. Segregation analysis was possible in five families, and showed that the deletions segregated with the disease.Conclusion: Deletions in the OPA1 gene were found in 10 patients presenting with phenotypic autosomal dominant optic neuropathy. Genetic testing for deletions in OPA1 should be offered for patients with clinically diagnosed ADOA and no OPA1 mutations detected by DNA sequencing analysis. © 2011 Almind et al; licensee BioMed Central Ltd. | Source Title: | BMC Medical Genetics | URI: | https://scholarbank.nus.edu.sg/handle/10635/181638 | ISSN: | 14712350 | DOI: | 10.1186/1471-2350-12-49 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_1471-2350-12-49.pdf | 347.26 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License